Complete Story
On-Demand Compounding CPE For Pharmacists and Pharmacy Technicians
A series of Compounding Home-Study On-Demand courses will be hosted on Ohio Pharmacists Foundation’s (OPF) virtual platform, LecturePanda. LecturePanda is the online platform where you will view on-demand CPE videos, complete post-activity quizzes and speaker evaluations. Once each videos has been viewed in full, post-activity quizzes and evaluations completed, you will use the platform to submit credit to the CPE Monitor. After your credit has been claimed and submitted, it will be automatically uploaded to the CPE Monitor by LecturePanda. (Please allow 24 hours for the system to process.)
Please note: These sessions will be available through December 31, 2022.
|
Larry Houck |
When the DEA Comes Calling: Preparing for and Managing that Inspection ACPE #0129-9999-22-016-H04-P credit: 0.1 CEU |
|
|
What do you do when the Drug Enforcement Administration (DEA) inspector shows up at your pharmacy? What is the extent of DEA inspection authority and what enforcement actions can occur? This session will help you prepare for and know what to expect during a DEA inspection, including do’s and don’ts, policies and procedures, and the importance of conducting a post-inspection mirror audit. CPE was originally part of EduCon 2022. |
||
|
Deborah Clark |
Veterinary Compounding: Considerations & Clinical Pearls ACPE #0129-9999-22-017-H07-P credit: 0.1 CEU |
|
|
Compounding for veterinary patients requires special considerations when choosing a route of administration and dosage form for a given species. Our speaker will provide an overview of toxicities to consider when choosing a commercially available drug product or when formulating a compounded product, as well as appropriate dosage forms for the canine, feline and equine patient. Unique dosage form options that may give a better therapeutic outcome in certain species will be included. CPE was originally part of EduCon 2022. |
||
|
Barbara Exum |
Compounder Ethics: The Code as Compliance Strategy ACPE credit: 0.1 CEU |
|
|
This session will review the new code of ethics adopted by Alliance for Pharmacy Compounding, The Pharmacy Compounding Professional’s Code of Ethics. Characteristics of ethical behavior in the practice of pharmacy and ethical principles as they relate to compounders will be included. Our speaker will also describe frameworks used in ethical decision-making that you can use when confronted with ethical dilemmas. CPE was originally part of EduCon 2022. |
||
|
Denise Frank |
Cultural Competency & Bias Training (CMS-Required) ACPE #0129-9999-22-019-H04-P credit: 0.1 CEU |
|
|
The Affordable Care Act’s Section 1557, “Nondiscrimination in Health Programs and Activities,” was created to reduce disparities in health care and prohibits discrimination on the basis of sex in federally funded health programs. This session will provide examples of discrimination, and review key provisions of the rule, including enforcement and consequences of noncompliance. Attendees will learn how to recognize types of discrimination and develop a plan for their work setting to become compliant. CPE was originally part of EduCon 2022. |
||
|
FACILITATOR: Alexander Pytlarz |
R&D Roundtable: How Compounders are Aiding Medical Research ACPE #0129-9999-22-020-H04-P credit: 0.1 CEU |
|
|
There is a wide range of medical research projects in which compounders are engaged and can be engaged. Our panel of speakers will provide attendees with an understanding of the research protocols under which compounders can engage in supporting medical research projects and explain how to cultivate relationships with medical research and identify R&D opportunities related to compounding. CPE was originally part of EduCon 2022. |
||
|
Peter Clapp Lisa Faast |
Implementing Pharmacogenomic Testing in Your Practice ACPE #0129-9999-22-021-H04-P credit: 0.1 CEU |
|
|
Adding pharmacogenomic testing to your pharmacy practice can increase revenues and improve patient outcomes. This session will include a review of single nucleotide polymorphisms (SNPs) in pharmacogenetic analyses and the possible consequences of metabolic enzyme polymorphism on drug disposition. You will learn how to identify potential patients for PGx testing, recognize compensation models for PGx services, and how to market this service to grow your pharmacy. CPE was originally part of EduCon 2022. |
||
|
Gus Bassani |
USP <795> BUDs: An Update ACPE #0129-9999-22-022-H07-P credit: 0.1 CEU |
|
|
USP Chapters have undergone much change in recent year, including standards for beyond-use dates. Our speaker will review USP’s process for standard creation, summarize the revisions proposed for USP <795> and discuss the next steps for the chapters. Attendees will be provided with information on where to find the proposed revisions to the chapters and the supplementary materials. CPE was originally part of EduCon 2022. |
||
|
Connie Sullivan |
USP <797> BUDs: An Update ACPE #0129-9999-22-023-H07-P credit: 0.1 CEU |
|
|
USP Chapters have recently undergone several changes, including standards for beyond-use dates. Our speaker will review USP’s process for standard creation, summarize the revisions proposed for USP <797> and discuss the next steps for the chapters. Attendees will learn where to find the proposed revisions to the chapters and the supplementary materials. CPE was originally part of EduCon 2022. |
||
|
Vanessa Pinheiro |
The Biopharmaceutical Classification System: What You Should Know ACPE #0129-9999-22-024-H07-P credit: 0.1 CEU |
|
|
This session will look at the classes of the Biopharmaceutical Classification System (BCS) and the importance of drug dissolution for absorption after oral administration of solid dosage forms. Excipients that could impact the dissolution of active pharmaceutical ingredients (APIs), considerations for formulation development when compounding from an API or an existing drug product, and literature related to the BCS and compounding pharmacy will be included. CPE was originally part of EduCon 2022. |
||
|
Brian Kelley |
USP: Minor Chapters, Major Impacts ACPE #0129-9999-22-025-H07-P credit: 0.1 CEU |
|
|
In this session, our speaker will outline regulatory considerations for USP Chapters and FDA guidelines, and explain USP <61> and USP <62> tests and how they determine if non-sterile products meet quality requirements. The significance of USP <51> preservative-effectiveness testing in compounding, the importance of a container closure system for a drug product, and the test requirements for compounded preparations in USP <1163> will be detailed as well. CPE was originally part of EduCon 2022. |
||
|
Mindy Cormier |
BUDs & Stability Studies Under the Proposed New USP Chapters ACPE #0129-9999-22-026-H07-P credit: 0.1 CEU |
|
|
Beyond-use dates have become a hot topic for compounding pharmacists. This session will review the discussion surrounding non-sterile and sterile beyond-use date appeals, and the importance of beyond-use dating for facilitating workflow efficiencies and patient access to personalized medicine. New requirements for default and extended beyond-use dating according to proposed USP <795> and <797> will be included, as well as what to look for in a stability-indicating study. Attendees will learn how to apply professional judgment in extrapolating stability data for extending beyond-use date. CPE was originally part of EduCon 2022. |
||
These home-study activities are targeted to pharmacists and pharmacy technicians interested in compounding. The continuing pharmacy education for this program is coordinated by the Ohio Pharmacists Foundation (OPF). To receive continuing pharmacy education credit, you must view the entire video, actively participate, answer post-activity questions, and complete evaluations to submit and claim credit through the LecturePanda.com platform, which will upload credits to the CPE Monitor.
The Ohio Pharmacists Foundation, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
